6 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 2 news categories, from Jul 6, 2026 through Jul 27, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Scientific research into the impact of creatine supplementation on cancer development is sparking conflicting reports regarding its potential risks and benefits.
The oncology community mourns the death of Maura Gillison, a doctor who transformed the treatment of mouth and throat cancers.
New research suggests a potential link between prolonged sedentary behavior and an increased risk of cancer-related mortality.
Scientists are investigating how the affordable muscle-building supplement creatine may help fight cancer and enhance immunotherapy.
Novartis is expanding its cancer-drug pipeline through the acquisition of U.K.-based biotech firm Myricx Bio in a deal valued up to $1.5 billion.